Reduction of cycles of neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian or primary peritoneal cancer (ROCOCO): study protocol for a phase III randomized controlled trial.
Soo Jin ParkSeung-Hyuk ShimYong-Il JiSang-Hoon KwonEun Ji LeeMaria LeeSuk Joon ChangSamina ParkSang Youn KimSung Jong LeeJae-Weon KimJu-Won RohSan Hui LeeTaejong SongHee Seung KimPublished in: BMC cancer (2020)
This study has been prospectively registered at ClinicalTrials.gov on Oct. 2nd, 2018 (NCT03693248, URL: https://clinicaltrials.gov/ct2/show/NCT03693248).
Keyphrases
- neoadjuvant chemotherapy
- phase iii
- randomized controlled trial
- locally advanced
- open label
- clinical trial
- lymph node
- sentinel lymph node
- papillary thyroid
- study protocol
- computed tomography
- squamous cell
- phase ii
- squamous cell carcinoma
- magnetic resonance imaging
- diabetic retinopathy
- contrast enhanced
- dual energy
- magnetic resonance
- positron emission tomography
- early stage